Clinical Trial Update: Biological Signatures, Probiotic Among Those With mTBI and PTSD [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating biological signatures and a probiotic in individuals with mild TBI and PTSD; study completed with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder
• Traumatic Brain Injury

Snippet

Sponsor: VA Office of Research and Development | Conditions: Mild Traumatic Brain Injury, Post Traumatic Stress Disorder | Phase 1 | Status: COMPLETED | Results posted: 2020-07-28